▲ BUY
7
/ 10
Conviction
$ Value
$42K
Shares
25,000
Price
$2
Filed
May 16
▶ Why this score? (7/10)
- ✓ Open market buy (+3)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Vogt Frederick G
Title
Interim CEO & General Counsel
CIK
0001719678
Roles
Director
Officer
Transaction Details
Transaction Date
2025-05-14
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
374,646
Footnotes
Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024.
Filing Info
Vogt Frederick G's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | IOVA | M | $0 |
| 2026-03-05 | IOVA | F | $123K |
| 2026-03-05 | IOVA | M | $0 |
| 2026-03-02 | IOVA | M | $0 |
| 2026-03-02 | IOVA | F | $86K |
| 2026-03-02 | IOVA | M | $0 |
| 2026-03-02 | IOVA | M | $0 |
| 2025-12-02 | IOVA | M | $0 |
| 2025-12-02 | IOVA | F | $9K |
| 2025-12-02 | IOVA | M | $0 |
Other Insiders at IOVA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
BILINSKY IGOR
Chief Operating Officer
|
— | — | 2026-03-05 |
|
Vogt Frederick G
Interim CEO & General Counsel
|
— | — | 2026-03-05 |
|
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
|
— | — | 2026-03-05 |
|
Puri Raj K.
Chief Regulatory Officer
|
— | — | 2026-03-05 |
|
Kirby Daniel Gordon
Chief Commercial Officer
|
— | — | 2026-02-24 |